Summary
The cornea was the first successful transplanted tissue more than 100 years ago. Our understanding about the immunological aspects of a corneal transplant has increased over the past 100 years and surgical techniques and medical treatment of corneal grafts have changed within the last decades. The cornea is now the most successfully transplanted tissue worldwide. The success story of corneal transplantation began with the understanding of the immunological aspects and the introduction of topical and systemic immunosuppressive treatment. Nowadays we have several surgical and medical options to get a prolonged graft survival, especially in eyes with a high risk for allograft rejection. In this review, we summarize the history of corneal transplantation and possible medical and surgical options to increase the success of corneal grafts.
Zusammenfassung
Die Hornhaut war vor nun mehr als 100 Jahren das erste erfolgreich transplantierte Gewebe. Während das Verständnis für ein erfolgreiches Hornhauttransplantat vor 100 Jahren noch fehlte, haben sich sowohl die Operationstechniken, als auch die konservative Therapie in den letzten Jahrzehnten zum Teil grundlegend geändert. Die Hornhaut ist nun weltweit nicht nur das am häufigsten transplantierte Gewebe, sondern auch das mit der besten Prognose. Die Erfolgsgeschichte der Keratoplastik begann mit dem Verständnis des immunologischen Aspektes und der Einführung lokaler und systemischer Immunsuppressiva. Heutzutage stehen uns zahlreiche dieser Wirkstoffe zur Verfügung, um ein gutes Transplantationsergebnis auch bei Patienten mit hohem Abstoßungsrisiko zu erreichen. Auch die Renaissance der lamellären Keratoplastik hat die Ergebnisse der Hornhauttransplantation deutlich verbessert. In dieser Übersichtsarbeit beschreiben wir sowohl die Geschichte der Keratoplastik als auch die neuen lokalen, systemischen und chirurgischen Optionen um die Erfolge von Hornhauttransplantaten zu verbessern.
Similar content being viewed by others
Literatur
Alberth B (1961) Prevention of vascularization of the transplanted cornea by orally administered prednisolone. Graefes Arch Clin Exp Ophthalmol 163: 562–574
Arancibia-Carcamo CV, Oral HB, Haskard DO, Larkin DF, George AJ (1998) Lipoadenofection-mediated gene delivery to the corneal endothelium: prospects for modulating graft rejection. Transplantation 65: 62–67
Ardjomand N, Müllner K, El-Shabrawi Y, Bergloff J, Hofmann-Wellenhof R, Reich M, Radner H (1999) Antigen pattern of the corneal Langerhans cell. Spektrum Augenheilkd 13: 14–16
Ardjomand N, Berghold A, Komericki P, Reich ME (1997) The significance of tissue storage time for success after corneal transplantation. Ophthalmologe 94: 285–289
Ardjomand N, Berghold A, Reich ME (1998) Loss of corneal Langerhans cells during storage in organ culture medium, Optisol and McCarey-Kaufman medium. Eye 12: 134–138
Ardjomand N, Hau S, McAlister JC, Bunce C, Galaretta D, Tuft SJ, Larkin DF (2007) Quality of vision and graft thickness in deep anterior lamellar and penetrating corneal allografts. Am J Ophthalmol 143: 228–235
Ardjomand N, Komericki P, Klein A, Mattes D, El-Shabrawi Y, Radner H (2005) ABO blood group expression in corneal allograft failures. Ophthalmologe 102: 981–986
Ardjomand N, Komericki P, Radner H, Aigner R, Reich ME (1997) Corneal Langerhans cells. Behavior during storage in organ culture. Ophthalmologe 94: 703–706
Ardjomand N, McAlister JC, Rogers NJ, Tan PH, George AJ, Larkin DF (2003) Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. Invest Ophthalmol Vis Sci 44: 3899–3905
Ardjomand N, Reich ME, Radner H (1998) Expression of blood group antigens A and/or B in diseased corneas. Curr Eye Res 17: 650–655
Baumgartner I, Mayr WR, Grabner G (1988) Why HLA-typing in keratoplasty? A review. Klin Monatsbl Augenheilkd 192: 629–633
Baumgartner I, Mayr WR, Grabner G (1989) Corneal grafting-strategy for optimal results. Tissue Antigens 34: 5–8
Baumgartner I, Mayr WR, Hajek-Rosenmayr A, Grabner G (1988) Differential effect of incompatibilities of the HLA-A and HLA-B locus on the success of corneal transplants. Klin Monatsbl Augenheilkd 193: 48–51
Bell KD, Campbell RJ, Bourne WM (2000) Pathology of late endothelial failure: late endothelial failure of penetrating keratoplasty: study with light and electron microscopy. Cornea 19: 40–46
Beutelspacher SC, Ardjomand N, Tan PH, Patton GS, Larkin DF, George AJ, McClure MO (2005) Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction. Exp Eye Res 80: 787–794
Bigger SL (1837) An inquiry into the possibility of transplanting the cornea with a view to relieving blindness. Dublin J Med Sci 11: 408–417
Birnbaum F, Bohringer D, Sokolovska Y, Sundmacher R, Reinhard T (2005) Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study. Transplantation 79: 964–968
Brown DC, Ellison ED, Kaufman HE (1969) Quantitative systemic corticosteroid effect on xenograft reaction. Am J Ophthalmol 67: 896–899
CCTS (1992) The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. Arch Ophthalmol 110: 1392–1403
CCTS (1993) Design and methods of The Collaborative Corneal Transplantation Studies. The Collaborative Corneal Transplantation Studies Research Group. Cornea 12: 93–103
Claerhout I, Beele H, De Bacquer D, Kestelyn P (2003) Factors influencing the decline in endothelial cell density after corneal allograft rejection. Invest Ophthalmol Vis Sci 44: 4747–4752
Comer RM, King WJ, Ardjomand N, Theoharis S, George AJ, Larkin DF (2002) Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. Invest Ophthalmol Vis Sci 43: 1095–1103
Cursiefen C, Schlotzer-Schrehardt U, Kuchle M, Sorokin L, Breiteneder-Geleff S, Alitalo K, Jackson D (2002) Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci 43: 2127–2135
Dieffenbach JB (1831) Beiträge zur Verpflanzung der Hornhaut. Festschr Ophthalmol (von Ammon) 1: 172–176
Fehervari Z, Rayner SA, Oral HB, George AJ, Larkin DF (1997) Gene transfer to ex vivo stored corneas. Cornea 16: 459–464
Filatov VP (1937) Transplantation of the cornea from preserved cadavers' eyes. Lancet 1: 1395–1397
Foster CS, Barney NP (1992) Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis. Doc Ophthalmol 80: 363–369
Game DS, Lechler RI (2002) Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 10: 101–108
George AJ, Arancibia-Carcamo CV, Awad HM, Comer RM, Fehevari Z, King WJ, Kadifachi M, Hudde T, Kerouedan-Lebosse C, Mirza F, Barbaros Oral H, Rayner SA, Tan PH, Tay E, Larkin DF (2000) Gene delivery to the corneal endothelium. Am J Respir Crit Care Med 162: 194–200
George AJ, Larkin DF (2004) Corneal transplantation: the forgotten graft. Am J Transplant 4: 678–685
Hamrah P, Liu Y, Zhang Q, Dana MR (2003) The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci 44: 581–589
Hargrave SL, Mayhew E, Hegde S, Niederkorn J, Taherzadeh S (2003) Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection? Transpl Immunol 11: 79–89
Hargrave SL, Taherzadeh S, Hegde S, Niederkorn J (2000) High-risk corneal allografts are capable of stimulating complement dependent cytolytic antibodies. Cornea 19: 521–525
Hart SL, Arancibia-Carcamo CV, Wolfert MA, Mailhos C, O'Reilly NJ, Ali RR, Coutelle C, George AJ, Harbottle RP, Knight AM, Larkin DF, Levinsky RJ, Seymour LW, Thrasher AJ, Kinnon C (1998) Lipid-mediated enhancement of transfection by a nonviral integrintargeting vector. Hum Gene Ther 9: 575–585
Hegde S, Mellon JK, Hargrave SL, Niederkorn JY (2002) Effect of alloantibodies on corneal allograft survival. Invest Ophthalmol Vis Sci 43: 1012–1018
Hudde T, Minassian DC, Larkin DF (1999) Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection. Br J Ophthalmol 83: 1348–1352
Hudde T, Rayner SA, Comer RM, Weber M, Isaacs JD, Waldmann H, Larkin DF, George AJ (1999) Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium. Gene Ther 6: 939–943
Hudde T, Rayner SA, De Alwis M, Thrasher AJ, Smith J, Coffin RS, George AJ, Larkin DF (2000) Adeno-associated and herpes simplex viruses as vectors for gene transfer to the corneal endothelium. Cornea 19: 369–373
Joseph A, Raj D, Shanmuganathan V, Powell R, Dua H (2007) Tacrolimus immunosuppression in high-risk corneal grafts. Br J Ophthalmol 91: 51–55
Khaireddin R, Wachtlin J, Hopfenmuller W, Hoffmann F (2003) HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection. Graefes Arch Clin Exp Ophthalmol 241: 1020–1028
Khodadoust AA, Silverstein AM (1966) Studies on the heterotopic transplantation of cornea to the skin. Surv Ophthalmol 11: 435–443
Khodadoust AA, Silverstein AM (1969) The survival and rejection of epithelium in experimental corneal transplants. Invest Ophthalmol 8: 169–179
Khodadoust AA, Silverstein AM (1972) Studies on the nature of the privilege enjoyed by corneal allografts. Invest Ophthalmol 11: 137–148
Khodadoust AA, Silverstein AM (1976) Induction of corneal graft rejection by passive cell transfer. Invest Ophthalmol 15: 89–95
Klebe S, Coster DJ, Sykes PJ, Swinburne S, Hallsworth P, Scheerlinck JP, Krishnan R, Williams KA (2005) Prolongation of sheep corneal allograft survival by transfer of the gene encoding ovine IL-12-p40 but not IL-4 to donor corneal endothelium. J Immunol 175: 2219–2226
Larkin DF (1994) Corneal allograft rejection. Br J Ophthalmol 78: 649–652
Larkin DF, Alexander RA, Cree IA (1997) Infiltrating inflammatory cell phenotypes and apoptosis in rejected human corneal allografts. Eye 11: 68–74
Larkin DF, Calder VL, Lightman SL (1997) Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection. Clin Exp Immunol 107: 381–391
Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381: 434–438
Liu Y, Hamrah P, Zhang Q, Taylor AW, Dana MR (2002) Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med 195: 259–268
Lorenzetti DW, Kaufman HE (1966) Experimental production of graft reactions with suppression by topical corticosteroids. Arch Ophthalmol 76: 274–281
Nelken D, Nelken E, Michaelson IC, Gurevitch J (1957) Studies on antigens in the human cornea and their relationship to corneal grafting in man. J Lab Clin Med 49: 745
Ono SJ (2004) The birth of transplantation immunology: the Billingham-Medawar experiments at Birmingham University and University College London. 1951. J Exp Biol 207: 4013–4014
Oral HB, Larkin DF, Fehervari Z, Byrnes AP, Rankin AM, Haskard DO, Wood MJ, Dallman MJ, George AJ (1997) Ex vivo adenovirusmediated gene transfer and immunomodulatory protein production in human cornea. Gene Ther 4: 639–647
Pahor D, Gracner B, Falez M, Gracner T (2007) Changing indications for penetrating keratoplasty over a 20-year period, 1985–2004. Klin Monatsbl Augenheilkd 224: 110–114
Patel SV, Hodge DO, Bourne WM (2005) Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty. Am J Ophthalmol 139: 311–319
Pels E, van der Gaag R (1984) HLA-A,B,C, and HLA-DR antigens and dendritic cells in fresh and organ culture preserved corneas. Cornea 3: 231–239
Philipp W, Gottinger W (1993) Leukocyte adhesion molecules in diseased corneas. Invest Ophthalmol Vis Sci 34: 2449–2459
Pleyer U, Milani JK, Dukes A, Chou J, Lutz S, Ruckert D, Thiel HJ, Mondino BJ (1995) Effect of topically applied anti-CD4 monoclonal antibodies on orthotopic corneal allografts in a rat model. Invest Ophthalmol Vis Sci 36: 52–61
Price MO, Price FW Jr (2006) Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes. Ophthalmology 113: 1785–1790
Reinhard T, Bohringer D, Enczmann J, Kogler G, Mayweg S, Wernet P, Sundmacher R (2003) HLA class I and II matching improves prognosis in penetrating normal-risk keratoplasty. Dev Ophthalmol 36: 42–49
Reinhard T, Bohringer D, Enczmann J, Kogler G, Mayweg S, Wernet P, Sundmacher R (2004) Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching. Eye 18: 269–277
Reinhard T, Bohringer D, Enczmann J, Kogler G, Wernet P, Bohringer S, Sundmacher R (2004) HLA class I/II matching and chronic endothelial cell loss in penetrating normal risk keratoplasty. Acta Ophthalmol Scand 82: 13–18
Reinhard T, Mayweg S, Reis A, Sundmacher R (2005) Topical FK506 as immunoprophylaxis after allogeneic penetrating normal-risk keratoplasty: a randomized clinical pilot study. Transpl Int 18: 193–197
Reinhard T, Mayweg S, Sokolovska Y, Seitz B, Mittelviefhaus H, Engelmann K, Voiculescu A, Godehardt E, Sundmacher R (2005) Systemic mycophenolate mofetil avoids immune reactions in penetrating high-risk keratoplasty: preliminary results of an ongoing prospectively randomized multicentre study. Transpl Int 18: 703–708
Reis A, Reinhard T, Voiculescu A, Kutkuhn B, Godehardt E, Spelsberg H, Althaus C, Sundmacher R (1999) Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial. Br J Ophthalmol 83: 1268–1271
Reisinger FR (1824) Die Keratoplastik. Ein Versuch zur Erweiterung der Augenheilkunde. Bayrische Annalen 1: 207
Richter S (1965) Untersuchung über Isoantikörper bei Keratoplastik. Graefe's Arch Clin Exp Ophthalmol 168: 131–135
Rogers NJ, Lechler RI (2001) Allorecognition. Am J Transplant 1: 97–102
Saini JS, Jain AK, Sukhija J, Saroha V (2003) Indications and outcome of optical partial thickness lamellar keratoplasty. Cornea 22: 111–113
Seitz B, Langenbucher A, Kus MM, Kuchle M, Naumann GO (1999) Nonmechanical corneal trephination with the excimer laser improves outcome after penetrating keratoplasty. Ophthalmology 106: 1156–1164; discussion 1165
Shimazaki J, Shimmura S, Ishioka M, Tsubota K (2002) Randomized clinical trial of deep lamellar keratoplasty vs penetrating keratoplasty. Am J Ophthalmol 134: 159–165
Shimmura S, Tsubota K (2006) Deep anterior lamellar keratoplasty. Curr Opin Ophthalmol 17: 349–355
Simon M, Fellner P, El-Shabrawi Y, Ardjomand N (2004) Influence of donor storage time on corneal allograft survival. Ophthalmology 111: 1534–1538
Sloper CM, Powell RJ, Dua HS (2001) Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. Ophthalmology 108: 1838–1844
Solano JM, Hodge DO, Bourne WM (2003) Keratometric astigmatism after suture removal in penetrating keratoplasty: double running versus single running suture techniques. Cornea 22: 716–720
Streilein JW (2003) New thoughts on the immunology of corneal transplantation. Eye 17: 943–948
Streilein JW, Masli S, Takeuchi M, Kezuka T (2002) The eye's view of antigen presentation. Hum Immunol 63: 435–443
Sundmacher R (2003) A clinician's outlook on HLA matching for keratoplasty. Dev Ophthalmol 36: 89–97
Suwan-Apichon O, Reyes JM, Griffin NB, Barker J, Gore P, Chuck RS (2006) Microkeratome versus femtosecond laser predissection of corneal grafts for anterior and posterior lamellar keratoplasty. Cornea 25: 966–968
Tambasco FP, Cohen EJ, Nguyen LH, Rapuano CJ, Laibson PR (1999) Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol 117: 445–449
Tuberville AW, Foster CS, Wood TO (1983) The effect of donor cornea epithelium removal on the incidence of allograft rejection reactions. Ophthalmology 90: 1351–1356
van Rooij J, Rijneveld WJ, Remeijer L, Volker-Dieben HJ, Eggink CA, Geerards AJ, Mulder PG, Doornenbal P, Beekhuis WH (2003) Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial. Ophthalmology 110: 1916–1919; discussion 1919
Volker-Dieben HJ, Schreuder GM, Claas FH, Doxiadis II, Schipper RF, Pels E, Persijn GG, Smits J, D'Amaro J (2003) Histocompatibility and corneal transplantation. Dev Ophthalmol 36: 22–41
von Hippel A (1878) Über Transplantation der Cornea. Graefes Arch Ophthalmol 24: 235–256
Wang X, Appukuttan B, Ott S, Patel R, Irvine J, Song J, Park JH, Smith R, Stout JT (2000) Efficient and sustained transgene expression in human corneal cells mediated by a lentiviral vector. Gene Ther 7: 196–200
Watson MP, George AJ, Larkin DF (2006) Differential effects of costimulatory pathway modulation on corneal allograft survival. Invest Ophthalmol Vis Sci 47: 3417–3422
Watson SL, Ramsay A, Dart JK, Bunce C, Craig E (2004) Comparison of deep lamellar keratoplasty and penetrating keratoplasty in patients with keratoconus. Ophthalmology 111: 1676–1682
Watson SL, Tuft SJ, Dart JK (2006) Patterns of rejection after deep lamellar keratoplasty. Ophthalmology 113: 556–560
Weijtens O, Schoemaker RC, Romijn FP, Cohen AF, Lentjes EG, van Meurs JC (2002) Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate. Ophthalmology 109: 1887–1891
Williams KA, Ash JK, Pararajasegaram P, Harris S, Coster DJ (1991) Long-term outcome after corneal transplantation. Visual result and patient perception of success. Ophthalmology 98: 651–657
Williams KA, Jessup CF, Coster DJ (2004) Gene therapy approaches to prolonging corneal allograft survival. Expert Opin Biol Ther 4: 1059–1071
Williams KA, Muehlberg SM, Lewis RF, Coster DJ (1995) How successful is corneal transplantation? A report from the Australian Corneal Graft Register. Eye 9: 219–227
Williams KA, Roder D, Esterman A, Muehlberg SM, Coster DJ (1992) Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry. Ophthalmology 99: 403–414
Wolf P, Jaeck D (2001) Xenograft: perpetual future of transplantation? Ann Chir 126: 101–103
Zirm E (1906) Eine erfolgreiche totale Keratoplastik. Graefes Arch Ophthalmol 64: 580
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ardjomand, N., Komericki, P., McAlister, J. et al. 100 Jahre erfolgreiche Hornhauttransplantation. Spektrum Augenheilkd. 21, 144–153 (2007). https://doi.org/10.1007/s00717-007-0202-4
Issue Date:
DOI: https://doi.org/10.1007/s00717-007-0202-4